Unprecedented international cooperation and focus have led to multiple effective and safe Covid-19 vaccines in less than a year, and created a blueprint for future vaccine development.
There are hundreds of Covid-19 vaccines in development, and some have produced very positive results in phase III clinical trials. How do some of the different vaccines work and compare?
Both the Pfizer-BioNTech and Moderna Covid-19 vaccines, unlike the vaccines we already use for other diseases, have been developed using ribonucleic acid (RNA) technology. So, how do they work, are they safe, and what else do we know about them?
The best of humanity has shone through the gloom of 2020. The dedication of scientists across the globe has been remarkable, not just for producing a string of lifesaving breakthroughs but for doing so at an unprecedented pace.
Having a range of Covid-19 vaccines available for people to use around the world will be essential to bringing the pandemic under control. Here’s why.
As heads of state and international organisations meet at the Paris Peace Forum, we ask whether investing in treatments now could help end this crisis.
Vaccines, tests and treatments, alongside well-equipped health systems, are the solutions to bringing the Covid-19 pandemic under control. But this won’t happen without urgent investment.
Finding and delivering Covid-19 treatments worldwide requires global collaboration at an unprecedented scale. This is being done through the ACT-Accelerator Therapeutics Partnership.
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.
We need a range of treatments to make Covid-19 preventable and treatable. Jeremy Farrar describes recent progress made by research and why more investment is needed.
Monoclonal antibodies, one of the most promising treatments for Covid-19, are usually expensive and not available worldwide. Lindsay Keir highlights what needs to be done to change that.